Ingredion Incorporated INGR
Set alert
98.93 USD +1.96 +2.02%
At close · Nov 2
98.93 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
97.17 Day range 98.95
93.30 52-week range 123.49
- YTD
- -10.28%
- 1 year
- -13.32%
- Open
- 97.50
- Prev close
- 96.97
- Mkt cap
- 6.24B
- Vol
- 680.56K
- Avg vol
- 653.58K
- EPS
- 9.19
- P/E
- 10.77
- Div yield
- 3.47%
More statistics
- Low
- 97.17
- High
- 98.95
- Forward P/E
- 8.81
- Beta
- 0.62
- Short ratio
- 7.04
- Inst. own
- 102.11%
- Dividend
- 3.32
- Ex-div date
- Sep 30, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 98.52
- 200-d avg
- 105.67
- 1y target
- 119.50
Analyst view
Consensus: hold
Hold
Price target (mean) 119.50 +20.8% upside
Now 98.93
- Target (low)
- 104.00
- Target (mean)
- 119.50
- Target (high)
- 150.00
Ratings (0m) 7 2 buy · 5 hold · 0 sell
- Strong buy1
- Buy1
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.60 | 2.53 – 2.64 | 2.75 | -5.6% | 1.80B | -0.9% | 6 |
| Next quarter | 2.67 | 2.39 – 2.80 | 2.53 | +5.5% | 1.75B | -0.3% | 6 |
| Current year | 10.46 | 10.16 – 10.63 | 11.13 | -6.1% | 7.20B | -0.3% | 7 |
| Next year | 11.23 | 10.80 – 11.84 | 10.46 | +7.4% | 7.35B | +2.1% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jun 9, 2026 | Oppenheimer | Downgrade | Outperform | Perform |
| May 6, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Mar 17, 2026 | Benchmark | Initiated | — | Buy |
| Feb 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 4, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 4, 2026 | Stephens & Co. | Reiterated | Equal-Weight | Equal-Weight |
| Nov 6, 2025 | Barclays | Downgrade | Overweight | Equal-Weight |
| Nov 5, 2025 | UBS | Maintained | Neutral | Neutral |
| Nov 5, 2025 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Nov 5, 2025 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Jul 9, 2025 | UBS | Maintained | Neutral | Neutral |
| Apr 22, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 7, 2025 | UBS | Downgrade | Buy | Neutral |
| Feb 5, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 5, 2025 | BMO Capital | Maintained | Market Perform | Market Perform |
| Feb 5, 2025 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Nov 15, 2024 | UBS | Maintained | Buy | Buy |
| Nov 6, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Nov 6, 2024 | Barclays | Maintained | Overweight | Overweight |
| Nov 6, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 21, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 15, 2024 | UBS | Maintained | Buy | Buy |
| Aug 9, 2024 | Barclays | Upgrade | Equal-Weight | Overweight |